- POSITIVE
Quarterly Revenue Jeevan Scientific Jun-2026 Quarterly Revenue is Rs 17 Cr which is growth of 100.1% YoY.
- POSITIVE
Quarterly Net Profit Jeevan Scientific Jun-2026 Quarterly Net Profit is Rs 2 Cr which is growth of 187.3% YoY.
83.51-1.20(-1.42%)
12,961
BSE Volume
BSE 05 Oct, 2026 3:31 PM (IST)
Jeevan Scientific quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Jeevan Scientific quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.2 | 18.7 | 17.1 | 10.7 | 8.6 | 9.1 | 12.1 | 10.5 | 12.6 | 10.2 | 10 | 8.3 | 10.7 | ||
Operating Exp. | 13.3 | 14.9 | 12.3 | 9 | 9.3 | 9.8 | 9.8 | 8.4 | 9.1 | 9.4 | 9 | 7.4 | 8.3 | |
Operating Profit | 3.6 | 3.5 | 4.7 | 1.5 | -1.1 | -0.9 | 2 | 1.9 | 3.4 | 0.6 | 1.1 | 0.7 | 2.1 | |
Operating Profit Margin % | 21.49% | 18.92% | 27.50% | 14.10% | -13.54% | -10.19% | 17.19% | 18.88% | 27.09% | 5.54% | 10.78% | 8.33% | 19.70% | |
Depr. | 1.4 | 1.4 | 1.4 | 1.5 | 1.5 | 1.5 | 1.2 | 1.3 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | |
Interest | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.2 | 0.2 | 0.1 | 0.3 | 0.2 | |
Profit Before Tax | 2.2 | 2.2 | 3.1 | -0.1 | -2.6 | -2.7 | 0.8 | 0.6 | 2.1 | -0.8 | -0.5 | -0.7 | 0.7 | |
Tax | 0.3 | 0.6 | 0.8 | -0 | -0.4 | -1.3 | 0.4 | 0.4 | 0.5 | -0 | -0.1 | -0.2 | 0.2 | |
Net Profit | 1.9 | 1.6 | 2.3 | -0.1 | -2.2 | -1.3 | 0.3 | 0.2 | 1.6 | -0.7 | -0.4 | -0.5 | 0.6 | |
EPS Adj. latest | 1 | 0.8 | 1.2 | -0 | -1.1 | -0.7 | 0.2 | 0.1 | 0.8 | -0.4 | -0.2 | -0.3 | 0.3 | |
Net profit TTM | 5.7 | 1.7 | -1.3 | -3.3 | -3 | 0.7 | 1.3 | 0.6 | -0 | -1.1 | -2.6 | -2.1 | -2.8 | |
Basic EPS TTM | 2.8 | 0.8 | -0.8 | -2.1 | -1.9 | 0.5 | 0.8 | 0.4 | -0 | -0.7 | -1.7 | -1.4 | -1.8 | |
Results PDF | ||||||||||||||
Result Notes |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Jeevan Scientific competitor comparison and performance snapshot within industry
Jeevan Scientific revenue mix: sales, profit, and capital employed breakups by segment
Jeevan Scientific annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Annual Revenue Jeevan Scientific Mar-2026 Annual Revenue is Rs 55 Cr which is growth of 24.6% YoY.
- POSITIVE
Annual Net Profit Jeevan Scientific Mar-2026 Annual Net Profit is Rs 2 Cr which is growth of 124.3% YoY.
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
24.7%
2Y CAGR
18.6%
3Y CAGR
14%
5Y CAGR
5.1%
7Y CAGR
11.1%
10Y CAGR
12%
Total Revenue Annual growth is higher than historical averages.
Net Profit Ann.
1Y CHG
142.9%
5Y CAGR
-31.5%
7Y CAGR
2.8%
10Y CAGR
15.6%
Net Profit Annual growth is stable compared to historical averages.
Operating Exp. Ann.
1Y CHG
22.6%
2Y CAGR
15.5%
3Y CAGR
9.2%
5Y CAGR
13.7%
7Y CAGR
12.5%
10Y CAGR
11.6%
Operating Expenses Annual Cr growth is higher than historical averages.
Jeevan Scientific balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Jeevan Scientific Mar-2025 Total Shareholders Fund is Rs 73 Cr which is growth of 44.0% YoY.
- POSITIVE
Total Assets Jeevan Scientific Mar-2025 Total Assets is Rs 99 Cr which is growth of 40.6% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
14.9% | 15.1% | 73.3 | 50.9 | 48.8 | 48.3 | 50.6 | 36.3 | 24.9 | 32.8 | 22.7 | 17.4 | 4.2 | ||
Minority Interest Liability Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
24.3% | 3.5% | 9.6 | 9.9 | 2.9 | 5 | 5.2 | 8.1 | 8.2 | 8 | 10.1 | 4.8 | 8.4 | ||
16.2% | -3.4% | 16.3 | 9.8 | 8.2 | 10.4 | 22.2 | 19.4 | 19.8 | 20 | 16.5 | 8.7 | 8 | ||
Total Capital Plus Liabilities Ann. | 15.9% | 9.3% | 99.3 | 70.6 | 59.9 | 63.8 | 77.9 | 63.8 | 52.9 | 60.8 | 49.3 | 31 | 20.6 | |
5.3% | 6.4% | 28 | 28.7 | 20.2 | 24 | 19.1 | 20.5 | 23.7 | 26.6 | 23.8 | 13.8 | 8.6 | ||
10.8% | 8.2% | 48.7 | 40.7 | 35.7 | 35.8 | 23.9 | 32.8 | 36.2 | 36.2 | 28.9 | 17.4 | 9.9 | ||
21.8% | 10.3% | 50.6 | 29.9 | 24.2 | 28 | 53.9 | 31 | 16.7 | 24.6 | 20.5 | 13.6 | 10.7 | ||
Total Assets Ann. | 15.9% | 9.3% | 99.3 | 70.6 | 59.9 | 63.8 | 77.9 | 63.8 | 52.9 | 60.8 | 49.3 | 31 | 20.6 | |
Contingent Liabilities plus Commitments Ann. | - | - | - | 0 | 0 | |||||||||
Bonus Equity Share Capital Ann. | - | - | - | |||||||||||
Non Current Investments Unquoted Book Value Ann. | - | - | - | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 0.5 | |||
Current Investments Unquoted Book Value Ann. | - | - | - |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Assets Ann.
1Y CHG
40.7%
2Y CAGR
28.8%
3Y CAGR
15.9%
5Y CAGR
9.3%
7Y CAGR
7.3%
10Y CAGR
17%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
66.3%
2Y CAGR
41%
3Y CAGR
16.2%
5Y CAGR
-3.4%
7Y CAGR
-2.9%
10Y CAGR
7.4%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
44%
2Y CAGR
22.6%
3Y CAGR
14.9%
5Y CAGR
15.1%
7Y CAGR
12.2%
10Y CAGR
33.1%
Total ShareHolders Funds Annual growth is higher than historical averages.
Jeevan Scientific ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Book Value Per Share Jeevan Scientific Mar-2025 Book Value Per Share is 37 Rs which is growth of 14.4% YoY.
- POSITIVE
ROE Jeevan Scientific Mar-2025 ROE is 2% which is growth of 0.8% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BVSH Ann. | 5.7% | 9.2% | 36.8 | 32.2 | 31.5 | 31.2 | 33.1 | 23.7 | 16.3 | 21.4 | 19.8 | 18.8 | 7 | |
RoA Ann. % | - | -37.7% | 1.66% | 1.04% | -1.75% | -4.71% | 15.74% | 17.65% | -14.77% | 2.23% | 0.50% | 3.33% | 2.03% | |
ROE Ann. % | - | -40.8% | 2.25% | 1.44% | -2.15% | -6.21% | 24.24% | 31.06% | -31.34% | 4.14% | 1.08% | 5.92% | 9.99% | |
ROCE Ann. % | - | -32.2% | 4.84% | 2.96% | -0.95% | -5.00% | 34.64% | 33.73% | -22.52% | 8.27% | 6.55% | 11.19% | 15.29% | |
Total Debt to Total Equity Ann. | 26% | 0% | 0.2 | 0.2 | 0.1 | 0.1 | 0.3 | 0.2 | 0.6 | 0.5 | 0.7 | 0.4 | 2.6 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
ROE Ann. %
1Y CHG
56.3%
5Y CAGR
-40.8%
7Y CAGR
-8.3%
10Y CAGR
-13.8%
ROE Annual % is stable compared to historical averages.
RoA Ann. %
1Y CHG
59.6%
5Y CAGR
-37.7%
7Y CAGR
-4.1%
10Y CAGR
-2%
RoA Annual % is stable compared to historical averages.
Current Ratio Ann.
2Y CAGR
1.7%
3Y CAGR
4.7%
5Y CAGR
14.1%
7Y CAGR
14.5%
10Y CAGR
9.1%
Current Ratio Annual growth is lower than historical averages.
Jeevan Scientific cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Cash From Operating Activity Jeevan Scientific Mar-2026 Cash From Operating Activity is Rs 3 Cr which is growth of -13.6% YoY.
- POSITIVE
Net Cash Flow Jeevan Scientific Mar-2026 Net Cash Flow is Rs 9 Cr which is growth of 3144.7% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | -11.2% | 2.6 | 3 | 2.7 | -8.8 | 27.1 | 4.7 | -1.2 | 2.4 | 3.7 | -8.1 | 4 | ||
Cash from Investing Act. Ann. | - | - | -13.9 | -9.8 | -4.7 | -7.3 | -2.2 | -0.8 | -1 | -6.2 | -12.4 | -6.4 | -4.1 | |
Cash from Financing Act. Ann. | - | - | 20.6 | 6.6 | -3.7 | -7.6 | -0.8 | -0.1 | 0.4 | 6.1 | 9.9 | 14.6 | 0.2 | |
- | 19.6% | 9.3 | -0.3 | -5.6 | -23.6 | 24.1 | 3.8 | -1.8 | 2.3 | 1.2 | 0 | 0.1 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
-13.3%
2Y CAGR
-1.9%
5Y CAGR
-11.2%
7Y CAGR
1.2%
10Y CAGR
-4.2%
Cash from Operating Activity Annual is falling faster than historical averages.
Cash from Financing Act. Ann.
1Y CHG
212.1%
7Y CAGR
19%
10Y CAGR
59%
Cash from Financing Annual Activity growth is stable compared to historical averages.
